They could do even better in a future recession as investors pour into under-appreciated defensive assets. Investors have piled into tech stocks to the point where they constitute a plurality of their portfolios, if not the large majority. When a downturn hits the market, a rotation out of tech is likely. All that excess liquidity may end up making its way to the following 3 ETFs. If you are an investor who is securing profits and is buying up dividend ETFs to weather a possible downturn instead, it's not a ...

[applause] At some point in life, we all become the caregiver. And what I'm sharing with you today is based on lived experience, hard work, and science with only one goal to inspire you and maybe help you look differently at something we think we all understand. That is how we care for others.Today we are facing an epidemic of burnouts in health care, in classrooms, and even in friendships. But what if the key to a truly humane society lies in a common skill, one that could benefit us all. Because the probl ...

Group 1 - The employment environment for U.S. job seekers in 2025 is expected to be challenging, with a projected unemployment rate of 4.4% as of September, the highest since October 2021 [3][4] - Job growth is weak, with increasing layoffs and a stagnant hiring rate, particularly in the healthcare sector, which accounted for 47.5% of annual job growth as of August [3][4] - Experts predict a continuation of the "low hiring, low layoffs" trend, with concerns about a potential mild recession impacting vulnerable groups [4] Group 2 - Gold futures are currently trading around 978.88 yuan per gram, with a 1.48% increase, indicating a short-term bullish trend [1] - The gold market is in a consolidation phase, having broken above the 940-950 range, with support levels identified between 968-965 yuan and resistance levels at 975-980 yuan [5] - Recent price movements suggest a normal technical correction rather than a trend reversal, with the market expected to maintain an upward trajectory as long as key support levels hold [5]

Meet the movers and shakers across industries like art, sports, AI, social media, healthcare and more. #ForbesUnder30Read more: https://t.co/e8L3DT968G https://t.co/QEj0kS07oa ...

Heard on the Street: Companies like Cigna and CVS are promising simpler drug prices, but the behind-the-scenes system remains complex https://t.co/VwbvflQ366 ...

Core Viewpoint - GE HealthCare is positioned for growth in the healthcare technology sector, with a new price target set by Jefferies indicating a potential increase in stock value [1][6] Company Overview - GE HealthCare specializes in medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, competing with major players like Siemens Healthineers and Philips Healthcare [1] - The company's current stock price is $85.55, reflecting a slight increase of 1.28% [2] - Over the past year, the stock has experienced significant volatility, with a high of $94.80 and a low of $57.65, and a market capitalization of approximately $39.08 billion [2][6] Strategic Partnerships - GE HealthCare has expanded its collaboration with Imaging Biometrics Ltd, enhancing its neuroimaging capabilities with advanced tools like FTB Express maps and QSMetric [3][5] - The FTB Express tool integrates with existing workflows, providing faster access to critical data for clinicians [4] - This partnership underscores GE HealthCare's commitment to innovation and improving patient outcomes, potentially strengthening its market position [5]

So, I have a confession to make. I've long been part of the plastic pollution problem. In [clears throat] some ways, I still am.And for a long time, I've been an unwitting contributor. We've been taught in medical school that much of the plastic equipment we use was essential. And indeed, much of it probably is still.We intubate babies with breathing tubes made of plastic. We feed adults who are malnourished or having difficulties after a surgical procedure with gastric tubing made of plastic. We filter out ...

Core Viewpoint - Cross Country Healthcare's stock (CCRN) experienced a decline of 6.16% on December 3rd, 2025, due to the lack of an update regarding its merger agreement with Aya Healthcare, which was a specified fallback deadline [1]. Company Summary - The stock price drop indicates market sensitivity to merger news and the importance of timely communication from the company regarding strategic developments [1]. Industry Context - The healthcare staffing industry, represented by companies like Cross Country Healthcare, is influenced by merger activities, which can significantly impact stock performance and investor sentiment [1].

Group 1 - The stock trading with Jim is considered one of the best turnaround stories of the year, highlighting a significant improvement in the performance of a previously poorly managed consumer stock, which is now viewed as an inexpensive healthcare stock [1] - The healthcare initiatives are deemed more important than past issues, suggesting a potential stock multiple of 12 to 13, which could elevate the stock price to the mid-90s [2] - Concerns exist regarding the recent stock movements, with anticipation for the upcoming JP Morgan Healthcare conference, which is expected to showcase strong stories from various companies [3] Group 2 - Companies like Eli Lilly, Johnson & Johnson, Merck, and Pfizer are expected to present significant developments, with Eli Lilly notably experiencing a decline in stock over several sessions [4] - Eli Lilly is investing in a new plant in Alabama, indicating confidence in its future product pipeline, particularly related to the GOP-1 pill [4]

Core Insights - NextPlat Corp has achieved nearly 75% sequential quarterly revenue growth in 340B contract revenue due to new business initiatives implemented in the second half of 2025 [1] Business Development and Growth Plans - The company's strategic focus is on increasing contracted healthcare revenue and expanding its communications services customer base and product portfolio [2] - Rodney Barreto, the Chairman, has taken on an expanded role in business development, resulting in two revenue-generating healthcare contracts secured earlier this year [2] - NextPlat is exploring joint ventures and potential acquisitions to expand its pharmacy services business both locally in Florida and nationally [2] Healthcare Segment Performance - Preliminary results from October 2025 to early December 2025 indicate that business development and customer engagement activities are expected to yield over 12,000 additional 340B and contracted prescriptions, contributing to sequential growth in quarterly volumes compared to Q3 2025 [3] Leadership and Strategic Direction - The Chairman expressed satisfaction with the progress made by the leadership team in refocusing and growing the business, indicating that the company is at an inflection point with increasing traction among customers [4] - The CEO noted that efforts to streamline operations and improve customer support are leading to positive sequential revenue improvements, with expectations for tangible financial progress in the near future [6] Company Overview - NextPlat is a global consumer products and services company that provides healthcare and technology solutions through e-commerce and retail channels [7] - The company operates an e-commerce communications division offering various products and services, as well as pharmacy and healthcare data management services in the U.S. through its subsidiary, Progressive Care [7]